Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology

ImpriMed, a California-based precision medicine startup, builds AI-powered dog cancer treatment technology that helps veterinarians identify the most suitable drugs for individual canine and feline blood cancers.   The startup, which centers on improving treatment outcomes of dogs and cats with cancer first, now aims to expand its precision medicine technology for human oncology applications.  “The […]

© 2023 TechCrunch. All rights reserved. For personal use only.

ai ai-powered ai technology biotech & health california cancer cancer treatment cats dog dogs drugs expand human identify imprimed medicine oncology pets precision precision medicine softbank ventures asia south korea startup technology treatment